dexamethasone sodium phosphate injection, solution
general injectables & vaccines, inc. - dexamethasone sodium phosphate (unii: ai9376y64p) (dexamethasone - unii:7s5i7g3jql) - a. intravenous or intramuscular administration . when oral therapy is not feasible and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, those products labeled for intravenous or intramuscular use are indicated as follows: 1. endocrine disorders . primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance). acute adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; mineralocorticoid supplementation may be necessary, particularly when synthetic analogs are used). preoperatively, and in the event of serious trauma or illness, in patients with known adrenal insufficiency or when adrenocortical reserve is doubtful. shock unresponsive to conventional therapy if adrenocortical insufficiency exists or is
cortexonavet 2 mg/ml inj. sol. i.v./i.artic./i.m. vial
laboratorios syva s.a. - dexamethasone sodium phosphate 2,63 mg/ml - eq. dexamethasone 2 mg/ml - solution for injection - 2 mg/ml - dexamethasone sodium phosphate 2.63 mg/ml - dexamethasone - cattle; horse; pig; dog; cat
dexa 0,2% 2 mg/ml inj. sol. i.v. vial
kela sa-nv - dexamethasone sodium phosphate 2,64 mg/ml - solution for injection - 2 mg/ml - dexamethasone sodium phosphate 2.64 mg/ml - dexamethasone - cattle
dexashot 2 mg/ml inj. sol. i.m./i.v./i.artic. vial
vet-agro multi-trade company sp. z o.o. - dexamethasone sodium phosphate 2,63 mg/ml - eq. dexamethasone 2 mg/ml - solution for injection - 2 mg/ml - dexamethasone sodium phosphate 2.63 mg/ml - dexamethasone - cattle; pig; cat; dog; horse
fordexin 2 mg/ml inj. sol. i.v./i.artic./i.m. vial
livisto int'l s.l. - dexamethasone sodium phosphate 2,63 mg/ml - eq. dexamethasone 2 mg/ml - solution for injection - 2 mg/ml - dexamethasone sodium phosphate 2.63 mg/ml - dexamethasone - dog; cat; horse; cattle; pig
dexamethasone sodium phosphate injection
civica, inc. - dexamethasone sodium phosphate (unii: ai9376y64p) (dexamethasone - unii:7s5i7g3jql) - a. intravenous or intramuscular administration. when oral therapy is not feasible and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, those products labeled for intravenous or intramuscular use are indicated as follows: 1. endocrine disorders primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance) acute adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; mineralocorticoid supplementation may be necessary, particularly when synthetic analogs are used) preoperatively, and in the event of serious trauma or illness, in patients with known adrenal insufficiency or when adrenocortical reserve is doubtful shock unresponsive to conventional therapy if adrenocortical insufficiency exists or is susp
dexamethasone sodium phosphate injection, solution
hf acquisition co llc, dba healthfirst - dexamethasone sodium phosphate (unii: ai9376y64p) (dexamethasone - unii:7s5i7g3jql) - a. intravenous or intramuscular administration. when oral therapy is not feasible and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, those products labeled for intravenous or intramuscular use are indicated as follows: 1. endocrine disorders. primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance). acute adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; mineralocorticoid supplementation may be necessary, particularly when synthetic analogs are used). preoperatively, and in the event of serious trauma or illness, in patients with known adrenal insufficiency or when adrenocortical reserve is doubtful. shock unresponsive to conventional therapy if adrenocortical insufficiency exists or is sus
dexamethasone sodium phosphate injection, solution
medical purchasing solutions, llc - dexamethasone sodium phosphate (unii: ai9376y64p) (dexamethasone - unii:7s5i7g3jql) - a. intravenous or intramuscular administration when oral therapy is not feasible and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, those products labeled for intravenous or intramuscular use are indicated as follows: 1. endocrine disorders. primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance). acute adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; mineralocorticoid supplementation may be necessary, particularly when synthetic analogs are used). preoperatively, and in the event of serious trauma or illness, in patients with known adrenal insufficiency or when adrenocortical reserve is doubtful. shock unresponsive to conventional therapy if adrenocortical insufficiency exists or is susp
glucadex 2 mg/ml inj. sol. i.v./i.m./i.artic./p.artic./s.c. vial
kepro b.v. - dexamethasone sodium phosphate 2,63 mg/ml - eq. dexamethasone 2 mg/ml - solution for injection - 2 mg/ml - dexamethasone sodium phosphate 2.63 mg/ml - dexamethasone - pig; horse; cattle; dog; cat; goat
dexamethasone sodium phosphate injection, solution
asclemed usa, inc. - dexamethasone sodium phosphate (unii: ai9376y64p) (dexamethasone - unii:7s5i7g3jql) - a. by intravenous or intramuscular injection when oral therapy is not feasible: 1. endocrine disorders: primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance). acute adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; mineralocorticoid supplementation may be necessary, particularly when synthetic analogs are used). preoperatively, and in the event of serious trauma or illness, in patients with known adrenal insufficiency or when adrenocortical reserve is doubtful. shock unresponsive to conventional therapy if adrenocortical insufficiency exists or is suspected. congenital adrenal hyperplasia. nonsuppurative thyroiditis. hypercalcemia associated with cancer. 2. rheumatic disorders: as adjunctive therapy for short-term administration (to tide the patie